Latest filing published 30 Oct 2023 for Rentokil Initial plc, €146.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -7.6%Entry £4.19 · Close at T+365 £3.88
- -40.3%Entry £6.10 · Close at T+365 £3.64
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
David Frear: trading record in brief
David Frear is a declared insider of Rentokil Initial plc, with filings sourced from RNS (LSE). Over a trading history stretching from 22 June 2023 to 27 October 2023, the count stands at 2 filings.
On the market, this insider has only ever bought: 2 purchases, €261 in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The newest entry dates from 30 October 2023: an open-market purchase of €146, in Rentokil Initial plc. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Companies and markets linked to David Frear
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 500 shares@ £0.254356.0% of flowNew York Stock ExchangeRNS:4952820Canonical exit: 25 Jan 2024 (T+90)
- 250 shares@ £0.39544.0% of flowNew York Stock ExchangeRNS:4813355Canonical exit: 20 Sept 2023 (T+90)
2 of 2 declarations